Microvolt T-wave alternans and electrophysiologic testing predict distinct arrhythmia substrates: Implications for identifying patients at risk for sudden cardiac death

Heart Rhythm

Volumn 7, Issue 6, 2010, Pages 763-768

  Amit, Guy ^a   Rosenbaum, David S ^b   Super, Dennis M ^b   Costantini, Otto ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Electrophysiologic study; Microvolt T wave alternans; Sudden cardiac death; Ventricular fibrillation; Ventricular tachycardia

Indexed keywords

AGED; ARTICLE; DEFIBRILLATOR; FEMALE; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART FUNCTION TEST; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MICROVOLT T WAVE ALTERNANS; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SUDDEN DEATH; T WAVE;

AGED; BIOLOGICAL MARKERS; DEATH, SUDDEN, CARDIAC; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; ELECTROPHYSIOLOGY; FEMALE; HUMANS; ISRAEL; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; STROKE VOLUME; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION; VENTRICULAR FUNCTION, LEFT;

EID: 77952527875     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2010.02.012     Document Type: Article

References (25)

1. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. J Am Coll Cardiol 48 (2006) 247-346
2. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335 (1996) 1933-1940
3. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
4. Kadish A., Dyer A., Daubert J.P., et al. Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350 (2004) 2151-2158
5. Bristow M.R., Saxon L.A., Boehmer J., et al. Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
6. Buxton A.E., Lee K.L., Fisher J.D., Josephson M.E., Prystowsky E.N., and Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 341 (1999) 1882-1890
7. Bardy G.H., Lee K.L., Mark D.B., et al. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
8. Bigger Jr. J.T. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. N Engl J Med 337 (1997) 1569-1575
9. Zareba W., and Moss A.J. Noninvasive risk stratification in postinfarction patients with severe left ventricular dysfunction and methodology of the MADIT II noninvasive electrocardiology substudy. J Electrocardiol 36 Suppl (2003) 101-108
10. Rosenbaum D.S., Jackson L.E., Smith J.M., et al. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med 330 (1994) 235-241
11. Bloomfield D.M., Bigger J.T., Steinman R.C., et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 47 (2006) 456-463
12. Costantini O., Rosenbaum D.S., Hohnloser S.H., et al., ABCD Investigators. The Alternans Before Cardioverter Defibrillator (ABCD) trial: a noninvasive strategy for primary prevention of sudden cardiac death using T-wave alternans. J Am Coll Cardiol 53 (2009) 471-479
13. Bloomfield D.M., Hohnloser S.H., and Cohen R.J. Interpretation and classification of microvolt T wave alternans tests. J Cardiovasc Electrophysiol 13 (2002) 502-512
14. Kaufman E.S., Bloomfield D.M., Steinman R.C., et al. "Indeterminate" microvolt T-wave alternans tests predict high risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 48 (2006) 1399-1404
15. Buxton A.E., Fisher J.D., Josephson M.E., et al., MUSTT Investigators. Prevention of sudden death in patients with coronary artery disease: the Multicenter Unsustained Tachycardia Trial (MUSTT). Prog Cardiovasc Dis 36 (1993) 215-226
16. Gold M.R., Ip J.H., Costantini O., Poole J.E., et al. Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy. Circulation 118 (2008) 2022-2028
17. Chow T., Kereiakes D.J., Onufer J., et al., MASTER Trial Investigators. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators?. The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial. J Am Coll Cardiol 52 (2008) 1607-1615
18. Narayan S.M. T-wave alternans and the susceptibility to ventricular arrhythmias. J Am Coll Cardiol 47 (2006) 269-281
19. Buxton A.E., Lee K.L., DiCarlo L., et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 342 (2000) 1937-1945
20. Daubert J.P., Zareba W., Hall W.J., et al., MADIT II Study Investigators. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol 47 (2006) 98-107
21. Pastore J.M., Girouard S.D., Laurita K.R., Akar F.G., and Rosenbaum D.S. Mechanism linking T-wave alternans to the genesis of cardiac fibrillation. Circulation 99 (1999) 1385-1394
22. Salerno-Uriarte J.A., De Ferrari G.M., Klersy C., et al., ALPHA Study Group Investigators. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study. J Am Coll Cardiol 50 (2007) 1896-1904
23. Pastore J.M., and Rosenbaum D.S. Role of structural barriers in the mechanism of alternans-induced reentry. Circ Res 87 (2000) 1157-1163
24. Rashba E.J., Osman A.F., Macmurdy K., et al. Enhanced detection of arrhythmia vulnerability using T wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation: a prospective study in subjects with chronic ischemic heart disease. J Cardiovasc Electrophysiol 15 (2004) 170-176
25. Buxton A.E., Lee K.L., Hafley G.E., et al., MUSTT Investigators. Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial. Circulation 106 (2002) 2466-2472